case_images: PMC3837367_01
case_images: Patient demonstrating scleral melting due to necrotizing scleritis, slitlamp image at presentation (a), image of patient demonstrating anti-glaucomatous valve tube extrusion (b).
case_images: TOOPHTJ-7-79_F1.jpg
case_images: PMC3837367_01_TOOPHTJ-7-79_F1.jpg
case_images: F1
case_images: Slit-lamp examination revealed a 4 x 2.5 mm area of scleral melting nasally (Fig. 1a). Patients presented with valve tube extrusion 3 years and 11 months after valve insertion (Fig. 1b).
case_images: Postoperative images demonstrating the grafts stability and epithiliazation (a) at the 1 year follow up of the patient with scleral melting and (b) at the six months follow up of the first patient with conjuctival melting.
case_images: TOOPHTJ-7-79_F2.jpg
case_images: PMC3837367_01_TOOPHTJ-7-79_F2.jpg
case_images: F2
case_images: During the one year follow up period, the grafts remained in place and no signs of inflammation or graft melting -rejection were evident, while all grafts were completely epithelialized (Fig. 2a.,b).